Clicky

Jazz Pharmaceuticals plc(JAZZ) News

Date Title
Feb 24 Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect
Feb 20 Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
Feb 20 Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Feb 12 Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?
Feb 11 Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
Oct 2 Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
Oct 1 Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now?
Sep 5 Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024
Sep 5 Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy Now
Sep 4 Jazz Pharmaceuticals Prices $850 Million Senior Notes Offering
Sep 4 Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases
Sep 3 Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases
Jul 25 Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting
Jul 25 Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Jul 24 Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Jul 23 Nanotechnology in medicine: Who are the leading public companies?
Jul 9 Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer
Jun 21 Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
Jun 21 Jazz Pharmaceuticals’ essential tremor drug falls flat in Phase IIb trial
Jun 20 Jazz Dives — But Key Rival Praxis Surges — On Essential Tremor Drug Failure